share_log

Pfizer | 4: Statement of changes in beneficial ownership of securities-Officer BOURLA ALBERT

Pfizer | 4: Statement of changes in beneficial ownership of securities-Officer BOURLA ALBERT

輝瑞 | 4:持股變動聲明-高管 BOURLA ALBERT
美股SEC公告 ·  12/03 05:21

Moomoo AI 已提取核心訊息

Albert Bourla, Chairman & CEO of Pfizer, reported no stock transactions as of 11/29/2024. The announcement indicates that there were no non-derivative securities transactions recorded for this period.This report is part of the regular disclosure requirements for executives, ensuring transparency in stock dealings. The absence of transactions suggests no recent changes in Bourla's stock holdings in Pfizer.Investors should note that while no transactions were reported, this does not necessarily imply future actions or intentions regarding stock holdings. The report serves as a compliance measure, reflecting the current status of stock transactions by the CEO.
Albert Bourla, Chairman & CEO of Pfizer, reported no stock transactions as of 11/29/2024. The announcement indicates that there were no non-derivative securities transactions recorded for this period.This report is part of the regular disclosure requirements for executives, ensuring transparency in stock dealings. The absence of transactions suggests no recent changes in Bourla's stock holdings in Pfizer.Investors should note that while no transactions were reported, this does not necessarily imply future actions or intentions regarding stock holdings. The report serves as a compliance measure, reflecting the current status of stock transactions by the CEO.
輝瑞董事長兼首席執行官阿爾伯特·布拉截至2024年11月29日沒有報告任何股票交易。該公告表明,在此期間沒有記錄非衍生證券交易。該報告是高管定期披露要求的一部分,旨在確保股票交易的透明度。沒有交易表明布拉在輝瑞的股票持有量最近沒有變化。投資者應注意,儘管沒有報告任何交易,但這並不一定意味着未來有關股票持有的行動或意圖。該報告是一項合規措施,反映了首席執行官股票交易的現狀。
輝瑞董事長兼首席執行官阿爾伯特·布拉截至2024年11月29日沒有報告任何股票交易。該公告表明,在此期間沒有記錄非衍生證券交易。該報告是高管定期披露要求的一部分,旨在確保股票交易的透明度。沒有交易表明布拉在輝瑞的股票持有量最近沒有變化。投資者應注意,儘管沒有報告任何交易,但這並不一定意味着未來有關股票持有的行動或意圖。該報告是一項合規措施,反映了首席執行官股票交易的現狀。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息